Stockscreener 앱 받기
231.95
0.39%
0.90
시장 영업 전:
233.90
1.95
+0.84%
Natera Inc 주식(NTRA)의 최신 뉴스
Neogenomics announces that Natera has voluntarily withdrawn its appeal in ongoing RaDaR patent litigation - marketscreener.com
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation - Business Wire
Castleark Management LLC Has $5.87 Million Stake in Natera, Inc. $NTRA - MarketBeat
Holocene Advisors LP Boosts Stake in Natera, Inc. $NTRA - MarketBeat
Fullerton Fund Management Co Ltd. Has $1.05 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Nikko Asset Management Americas Inc. - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Engineers Gate Manager LP Sells 30,042 Shares of Natera, Inc. $NTRA - MarketBeat
GCM Grosvenor Holdings LLC Sells 6,475 Shares of Natera, Inc. $NTRA - MarketBeat
Gilder Gagnon Howe & Co. LLC Decreases Stake in Natera, Inc. $NTRA - MarketBeat
Bellevue Group AG Raises Stock Position in Natera, Inc. $NTRA - MarketBeat
AQR Capital Management LLC Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Exelixis (EXEL) and Natera (NTRA) - The Globe and Mail
Caption Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Joins Phase II Breast Cancer Study with Innovative DNA Testing - GuruFocus
Maverick Capital Ltd. Reduces Position in Natera, Inc. $NTRA - MarketBeat
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer - Yahoo Finance
Natera Completes Acquisition Of Foresight Diagnostics For Up To $450 Million - Pulse 2.0
Natera New Test Data Could Change How Doctors Manage Breast CancerNatera (NASDAQ:NTRA) - Benzinga
Is It Too Late to Consider Natera After a 511% Three Year Surge? - simplywall.st
Natera stock rating reiterated at Buy by TD Cowen on solid momentum - Investing.com India
Is It Too Late To Consider Natera After Its Recent 12.8% Price Surge? - Yahoo Finance
California Public Employees Retirement System Purchases 29,296 Shares of Natera, Inc. $NTRA - MarketBeat
Frontier Capital Management Co. LLC Has $65.04 Million Position in Natera, Inc. $NTRA - MarketBeat
Baird Financial Group Inc. Has $4.50 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by Amundi - MarketBeat
Natera (NTRA) Unveils Promising Results from Phase III Breast Ca - GuruFocus
Natera (NASDAQ: NTRA) PALLAS: Signatera MRD‑positive group shows 13.4‑21.5 hazard ratios - Stock Titan
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post‑Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2‑ Breast Cancer - Yahoo Finance
Natera acquires Foresight Diagnostics for up to $450M - MedTech Dive
Preimplantation Genetics Diagnosis Market size to exceed - openPR.com
Natera, Inc. $NTRA Stake Lowered by Blue Water Life Science Advisors LP - MarketBeat
Cerity Partners LLC Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Rowan Chapman Sells 4,366 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera director Chapman sells shares for $1.06 million By Investing.com - Investing.com South Africa
Natera director Chapman sells shares for $1.06 million - Investing.com
What's Driving the Market Sentiment Around Natera Inc? - Benzinga
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Makes New $1.24 Million Investment in Natera, Inc. $NTRA - MarketBeat
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting - marketscreener.com
Wilson Sonsini Advises Foresight Diagnostics on Acquisition by Natera - Wilson Sonsini
Natera's (NTRA) Buy Rating Reiterated at Canaccord Genuity Group - MarketBeat
Natera, Inc. Stock (NTRA) Opinions on Foresight Acquisition and Signatera Data - Quiver Quantitative
BTIG Research Boosts Natera (NASDAQ:NTRA) Price Target to $260.00 - MarketBeat
Natera stock rises after Canaccord reiterates Buy rating following Foresight acquisition - Investing.com UK
Guggenheim Capital LLC Sells 4,628 Shares of Natera, Inc. $NTRA - MarketBeat
Natera purchases Foresight Diagnostics - Yahoo Finance
Natera Makes High-Conviction Moves to Seize the Lucrative Oncology Frontier; Will It Succeed? - Smartkarma
Federated Hermes Inc. Has $129.71 Million Position in Natera, Inc. $NTRA - MarketBeat
Jump Financial LLC Purchases 18,821 Shares of Natera, Inc. $NTRA - MarketBeat
Invesco Ltd. Sells 165,294 Shares of Natera, Inc. $NTRA - MarketBeat
Natera Acquires Foresight Diagnostics - Oncodaily
Natera acquires Foresight Diagnostics to expand cancer detection capabilities By Investing.com - Investing.com Nigeria
Should Natera’s (NTRA) New Share Offering and Signatera Lymphoma Data Require Action From Investors? - simplywall.st
Dir Chapman Files To Sell 4,366 Of Natera Inc [NTRA] - TradingView
Natera envisions cancer-testing future with $450M Foresight buy - BioWorld MedTech
Boulder diagnostics co. bought by Austin biotech giant in $450M deal - The Business Journals
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Working capital per share of Natera, Inc. – DUS:45E - TradingView
Natera buys Foresight Diagnostics in cancer testing deal worth up to $450M - Fierce Biotech
Austin biotech giant Natera acquires Colorado diagnostics company - The Business Journals
Natera (NASDAQ:NTRA) Hits New 1-Year HighWhat's Next? - MarketBeat
Natera Buys Foresight To Boost Super-Early Cancer Detection Tech - Benzinga
ETFs Investing in Natera, Inc. Stocks - TradingView
Natera Acquires Foresight Diagnostics for $275 Million - TipRanks
Natera Completes Foresight Diagnostics Acquisition in All-Stock Deal - marketscreener.com
Natera acquires Foresight Diagnostics - marketscreener.com
Natera acquires Foresight Diagnostics to expand cancer detection capabilities - Investing.com
1.97%
자본화:
|
볼륨(24시간):